This educational and promotional event is organised and funded by Flynn Pharma Ltd.
Measuring Stimulant Treatment Response Using Objective Measurements for Patients with ADHD
Agenda
Dr Carsten Vogt is a consultant child & adolescent psychiatrist and clinical lead for the ADHD Specialist CAMHS pathway at CYPF Berkshire. Dr Vogt has a special interest in the use of objective measurements for diagnostic assessment and measuring of treatment response in ADHD. He introduced the QbTest as part of the standard routine ADHD assessment in Berkshire in 2008 and published several papers on its clinical application. Dr Vogt has a particular interest in the effects of physical exercise on alleviating symptoms of ADHD and its consideration as a therapeutic intervention or adjunct with standard treatments for ADHD.
What will the webinar cover?
Key learning objectives
- To examine the efficacy of ADHD treatments for children and young people using objective measures
